NewcelX Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	1.35	0.81	1.41
Research & Development	1.13	0.99	1.61
Other Operating Expenses	0.09	0.27	-
Total Operating Expenses	2.56	2.07	3.02
Operating Income	-2.56	-2.07	-3.02
Interest Income	0.37	0.01	0.04
Interest Expense	-6.11	-5.14	-0.35
Total Non-Operating Income (Expense)	-5.74	-5.13	-0.32
Pretax Income	-8.3	-7.2	-3.33
Net Income	-8.3	-7.2	-3.33
Net Income to Common	-8.3	-7.2	-3.33
Shares Outstanding (Basic)	4	3	3
Shares Outstanding (Diluted)	4	3	3
Shares Change (YoY)	29.89%	0.14%	-
EPS (Basic)	-2.16	-2.43	-1.13
EPS (Diluted)	-2.16	-2.43	-1.13
Free Cash Flow	-2.77	-1.07	-3.45
Free Cash Flow Per Share	-0.72	-0.36	-1.17
EBITDA	-2.51	-1.65	-2.4
EBIT	-2.56	-2.07	-3.02